Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
Clinical trial NCT06875128 · RECRUITING
Trial details
- NCT number
- NCT06875128
- Sponsor
- Delcath Systems Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-29
- Primary completion
- 2029-05-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.